Status:

COMPLETED

Fasted Evening Exercise: Performance and Compensatory Eating

Lead Sponsor:

Nottingham Trent University

Collaborating Sponsors:

Loughborough University

Conditions:

Obesity

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

This study will compare the appetite, energy intake, and exercise performance responses to a bout of exercise completed in the evening after an extended period of fasting with a similar bout of exerci...

Detailed Description

Regular exercise is known to be a successful strategy for improving several facets of health and maintaining body weight. However, many people are not engaging in enough exercise, and some may not be ...

Eligibility Criteria

Inclusion

  • Non-smokers.
  • Have maintained a stable weight for 6 months (self-reported).
  • No history of gastric, digestive, cardiovascular or renal disease (self-reported).
  • Female specific: must be using a monophasic, low dose combined OCP (containing less than 50μg oestradiol and a synthetic progestin) OR females with regular menstrual cycles (self-reported).

Exclusion

  • Have an unusual eating pattern (i.e., extended fasting periods \>8h other than overnight - self-reported).
  • Severe food allergies, dislike or intolerance of study foods or drinks.
  • Currently undergoing a lifestyle intervention (structured diet or exercise)
  • Diagnosis of a condition or currently undergoing treatment therapy known to affect glucose or lipid metabolism (e.g., type-2 diabetes, taking statins), or contraindications to exercise.
  • Use of medication or supplements that may affect hormone concentrations.
  • Excessive alcohol consumption (\>14 units/week).
  • Intensive training schedule (\>10 hours/week).
  • Having received a positive COVID-19 test in the 6-month period prior to participation.
  • Female specific: currently pregnant or breastfeeding, the use of any hormonal contraception, and the self-reporting of short (\<24 d), long (\>35 d), or irregular menstrual cycles.

Key Trial Info

Start Date :

February 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 23 2021

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04742530

Start Date

February 8 2021

End Date

June 23 2021

Last Update

August 5 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Loughborough University

Loughborough, United Kingdom, LE11 3TU

2

Nottingham Trent University

Nottingham, United Kingdom, NG11 8NS